XML 26 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Stockholders' Equity and Dilutive Equity Instruments
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

(5)

STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS

 

Accumulated Other Comprehensive Income (Loss)

 

The changes in accumulated other comprehensive income (loss) (OCI) by component, net of tax, for the three months ended March 31, 2021 and 2020 are as follows:

 

  

Three Months Ended

 
  

March 31,

  

March 31,

 

(In thousands)

 

2021

  

2020

 

Balance at December 31, 2020 and 2019

 $(804) $(236)

Pension benefits recognized in OCI

  (71)  369 

Balance at March 31, 2021 and 2020

 $(875) $133 

 

Dilutive Equity Instruments

 

We had 3,171,497 and 2,133,439 incremental "in-the-money" warrants, restricted stock units and stock options at March 31, 2021 and 2020, respectively, which are as follows:

 

Total shares outstanding including warrants and restricted stock units

 

March 31, 2021

  

March 31, 2020

 

Common shares outstanding

  40,731,777   40,259,917 

New creditor warrants (strike price $0.001 per common share)

  657,203   821,308 

GulfMark creditor warrants (strike price $0.01 per common share)

  815,575   952,154 

Restricted stock units and stock options

  1,698,719   359,977 

Total

  43,903,274   42,393,356 

 

We also had 5,923,399 shares of “out-of-the-money” warrants outstanding at both March 31, 2021 and 2020. Included in these “out-of-the-money” warrants are Series A Warrants, Series B Warrants and GLF Equity Warrants which have exercise prices of $57.06, $62.28, and $100.00, respectively. No warrants or restricted stock units, whether in the money or out of the money, are included in our loss per share calculations because the effect of such inclusion is antidilutive.